Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [[maximum depth reached]]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'interviews/dinesh-thakur-an-ex-ranbaxy-employee-who-blew-the-whistle-on-the-company-interviewed-by-the-economic-times-21284/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/interviews/dinesh-thakur-an-ex-ranbaxy-employee-who-blew-the-whistle-on-the-company-interviewed-by-the-economic-times-21284/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [[maximum depth reached]]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'interviews/dinesh-thakur-an-ex-ranbaxy-employee-who-blew-the-whistle-on-the-company-interviewed-by-the-economic-times-21284/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/interviews/dinesh-thakur-an-ex-ranbaxy-employee-who-blew-the-whistle-on-the-company-interviewed-by-the-economic-times-21284/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67fcd85039908-trace').style.display = (document.getElementById('cakeErr67fcd85039908-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67fcd85039908-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67fcd85039908-code').style.display = (document.getElementById('cakeErr67fcd85039908-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67fcd85039908-context').style.display = (document.getElementById('cakeErr67fcd85039908-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67fcd85039908-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67fcd85039908-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 21139,
		&#039;title&#039; =&gt; &#039;Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, interviewed by The Economic Times&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Economic Times&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Indian pharmaceutical company Ranbaxy recently paid $500 million to the US government to settle civil and criminal charges for making fraudulent statements to the US FDA and selling adulterated drugs in the US. Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, talks to ET about the five-year long investigation and the future of generic drug companies in the US. Edited Excerpts:&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* You think you would have found support from the Indian authorities had you carried this &#039;expose&#039; in India?&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
A FDA is probably a mature regulatory organisation globally. I have worked in this industry for long, apart from the two years in Ranbaxy. I know how FDA works, what laws and regulations are followed, so it was natural for me to contact FDA.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* The Fortune story on Ranbaxy had quite a few revelations. Did you approach the top management, like Malvinder Singh and inform him of what was happening?&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
I was in touch with Dr Kumar, he was talking to the board. So, I was keeping him informed about my findings in the investigation.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* Have you met Malvinder Singh?&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
I have met him many times. I used to run portfolio review meetings for the company since I was the head of portfolio management, and he was head of business. So, he used to attend those meetings. I am not sure if he remembers that, but yes I have met him.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* Malvinder Singh in an interview has maintained that he never met you, and doesn&#039;t know who you are. Your comments...&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
I am sure he meets many people, and I am sure it is difficult for him to remember.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* The journey must have been quite frightening...&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
There&#039;s no legal framework to do something like this in India. You had to work hard to get to every document, so it was very difficult to navigate.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* Do other Indian companies follow regulatory measures to the book?&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
I have no idea what other Indian companies do, I have worked in only one Indian company and can speak about that company. So, I have no basis or information to talk about other companies.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* Do you think Indians should be worried about the quality of drugs that they take?&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
That&#039;s a question Indian regulators must answer. I am not in a position to answer questions on behalf of the safety of medicines made by manufacturers in India. All I can say is that in this particular case, it was not possible for me to accept what was happening. I made sure that patients didn&#039;t suffer because of the quality of medicines made by Ranbaxy.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* While the investigations were on, did you worry about your and your family&#039;s safety?&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
Thakur&#039;s attorney Andrew Beato responds: The process of being a whistle blower is inherently complex. It is a long process and there are a range of issues that every whistle blower has to contend with, from the future ability to choose employment to personal safety. So, in this particular case, we made sure all of his concerns were properly addressed.
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;em&gt;The Economic Times, 27 May, 2013, &lt;a href=&quot;http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms&quot;&gt;http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms&lt;/a&gt;&lt;/em&gt; 
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;strong&gt;Image Courtesy: The Economic Times&lt;/strong&gt; &lt;br /&gt;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Economic Times, 27 May, 2013, http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms&#039;,
		&#039;article_img&#039; =&gt; &#039;im4change_72Thakur.jpg&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;im4change_72Thakur.jpg&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 14,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;dinesh-thakur-an-ex-ranbaxy-employee-who-blew-the-whistle-on-the-company-interviewed-by-the-economic-times-21284&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 21284,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 21139,
	&#039;metaTitle&#039; =&gt; &#039;Interviews | Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, interviewed by The Economic Times&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Health,medicines,generic drugs,Ranbaxy,Whistleblower Protection Law&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Economic Times


Indian pharmaceutical company Ranbaxy recently paid $500 million to the US government to settle civil and criminal charges for making fraudulent statements to the US FDA and selling adulterated drugs in the US. Dinesh Thakur, an ex-Ranbaxy employee...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Economic Times&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Indian pharmaceutical company Ranbaxy recently paid $500 million to the US government to settle civil and criminal charges for making fraudulent statements to the US FDA and selling adulterated drugs in the US. Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, talks to ET about the five-year long investigation and the future of generic drug companies in the US. Edited Excerpts:&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* You think you would have found support from the Indian authorities had you carried this &#039;expose&#039; in India?&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;A FDA is probably a mature regulatory organisation globally. I have worked in this industry for long, apart from the two years in Ranbaxy. I know how FDA works, what laws and regulations are followed, so it was natural for me to contact FDA.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* The Fortune story on Ranbaxy had quite a few revelations. Did you approach the top management, like Malvinder Singh and inform him of what was happening?&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;I was in touch with Dr Kumar, he was talking to the board. So, I was keeping him informed about my findings in the investigation.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* Have you met Malvinder Singh?&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;I have met him many times. I used to run portfolio review meetings for the company since I was the head of portfolio management, and he was head of business. So, he used to attend those meetings. I am not sure if he remembers that, but yes I have met him.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* Malvinder Singh in an interview has maintained that he never met you, and doesn&#039;t know who you are. Your comments...&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;I am sure he meets many people, and I am sure it is difficult for him to remember.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* The journey must have been quite frightening...&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;There&#039;s no legal framework to do something like this in India. You had to work hard to get to every document, so it was very difficult to navigate.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* Do other Indian companies follow regulatory measures to the book?&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;I have no idea what other Indian companies do, I have worked in only one Indian company and can speak about that company. So, I have no basis or information to talk about other companies.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* Do you think Indians should be worried about the quality of drugs that they take?&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;That&#039;s a question Indian regulators must answer. I am not in a position to answer questions on behalf of the safety of medicines made by manufacturers in India. All I can say is that in this particular case, it was not possible for me to accept what was happening. I made sure that patients didn&#039;t suffer because of the quality of medicines made by Ranbaxy.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* While the investigations were on, did you worry about your and your family&#039;s safety?&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;Thakur&#039;s attorney Andrew Beato responds: The process of being a whistle blower is inherently complex. It is a long process and there are a range of issues that every whistle blower has to contend with, from the future ability to choose employment to personal safety. So, in this particular case, we made sure all of his concerns were properly addressed.&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&lt;em&gt;The Economic Times, 27 May, 2013, &lt;a href=&quot;http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms&quot; title=&quot;http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms&quot;&gt;http://economictimes.indiatimes.com/opinion/interviews/i-h&lt;br /&gt;ope-the-indian-law-protects-people-like-me-dinesh-thakur/a&lt;br /&gt;rticleshow/20284048.cms&lt;/a&gt;&lt;/em&gt; &lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&lt;strong&gt;Image Courtesy: The Economic Times&lt;/strong&gt; &lt;br /&gt;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 21139,
	&#039;title&#039; =&gt; &#039;Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, interviewed by The Economic Times&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Economic Times&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Indian pharmaceutical company Ranbaxy recently paid $500 million to the US government to settle civil and criminal charges for making fraudulent statements to the US FDA and selling adulterated drugs in the US. Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, talks to ET about the five-year long investigation and the future of generic drug companies in the US. Edited Excerpts:&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* You think you would have found support from the Indian authorities had you carried this &#039;expose&#039; in India?&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
A FDA is probably a mature regulatory organisation globally. I have worked in this industry for long, apart from the two years in Ranbaxy. I know how FDA works, what laws and regulations are followed, so it was natural for me to contact FDA.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* The Fortune story on Ranbaxy had quite a few revelations. Did you approach the top management, like Malvinder Singh and inform him of what was happening?&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
I was in touch with Dr Kumar, he was talking to the board. So, I was keeping him informed about my findings in the investigation.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* Have you met Malvinder Singh?&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
I have met him many times. I used to run portfolio review meetings for the company since I was the head of portfolio management, and he was head of business. So, he used to attend those meetings. I am not sure if he remembers that, but yes I have met him.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* Malvinder Singh in an interview has maintained that he never met you, and doesn&#039;t know who you are. Your comments...&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
I am sure he meets many people, and I am sure it is difficult for him to remember.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* The journey must have been quite frightening...&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
There&#039;s no legal framework to do something like this in India. You had to work hard to get to every document, so it was very difficult to navigate.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* Do other Indian companies follow regulatory measures to the book?&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
I have no idea what other Indian companies do, I have worked in only one Indian company and can speak about that company. So, I have no basis or information to talk about other companies.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* Do you think Indians should be worried about the quality of drugs that they take?&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
That&#039;s a question Indian regulators must answer. I am not in a position to answer questions on behalf of the safety of medicines made by manufacturers in India. All I can say is that in this particular case, it was not possible for me to accept what was happening. I made sure that patients didn&#039;t suffer because of the quality of medicines made by Ranbaxy.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* While the investigations were on, did you worry about your and your family&#039;s safety?&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
Thakur&#039;s attorney Andrew Beato responds: The process of being a whistle blower is inherently complex. It is a long process and there are a range of issues that every whistle blower has to contend with, from the future ability to choose employment to personal safety. So, in this particular case, we made sure all of his concerns were properly addressed.
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;em&gt;The Economic Times, 27 May, 2013, &lt;a href=&quot;http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms&quot;&gt;http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms&lt;/a&gt;&lt;/em&gt; 
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;strong&gt;Image Courtesy: The Economic Times&lt;/strong&gt; &lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Economic Times, 27 May, 2013, http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms&#039;,
	&#039;article_img&#039; =&gt; &#039;im4change_72Thakur.jpg&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;im4change_72Thakur.jpg&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 14,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;dinesh-thakur-an-ex-ranbaxy-employee-who-blew-the-whistle-on-the-company-interviewed-by-the-economic-times-21284&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 21284,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 21139
$metaTitle = &#039;Interviews | Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, interviewed by The Economic Times&#039;
$metaKeywords = &#039;Health,medicines,generic drugs,Ranbaxy,Whistleblower Protection Law&#039;
$metaDesc = &#039;
-The Economic Times


Indian pharmaceutical company Ranbaxy recently paid $500 million to the US government to settle civil and criminal charges for making fraudulent statements to the US FDA and selling adulterated drugs in the US. Dinesh Thakur, an ex-Ranbaxy employee...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Economic Times&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Indian pharmaceutical company Ranbaxy recently paid $500 million to the US government to settle civil and criminal charges for making fraudulent statements to the US FDA and selling adulterated drugs in the US. Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, talks to ET about the five-year long investigation and the future of generic drug companies in the US. Edited Excerpts:&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* You think you would have found support from the Indian authorities had you carried this &#039;expose&#039; in India?&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;A FDA is probably a mature regulatory organisation globally. I have worked in this industry for long, apart from the two years in Ranbaxy. I know how FDA works, what laws and regulations are followed, so it was natural for me to contact FDA.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* The Fortune story on Ranbaxy had quite a few revelations. Did you approach the top management, like Malvinder Singh and inform him of what was happening?&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;I was in touch with Dr Kumar, he was talking to the board. So, I was keeping him informed about my findings in the investigation.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* Have you met Malvinder Singh?&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;I have met him many times. I used to run portfolio review meetings for the company since I was the head of portfolio management, and he was head of business. So, he used to attend those meetings. I am not sure if he remembers that, but yes I have met him.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* Malvinder Singh in an interview has maintained that he never met you, and doesn&#039;t know who you are. Your comments...&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;I am sure he meets many people, and I am sure it is difficult for him to remember.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* The journey must have been quite frightening...&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;There&#039;s no legal framework to do something like this in India. You had to work hard to get to every document, so it was very difficult to navigate.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* Do other Indian companies follow regulatory measures to the book?&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;I have no idea what other Indian companies do, I have worked in only one Indian company and can speak about that company. So, I have no basis or information to talk about other companies.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* Do you think Indians should be worried about the quality of drugs that they take?&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;That&#039;s a question Indian regulators must answer. I am not in a position to answer questions on behalf of the safety of medicines made by manufacturers in India. All I can say is that in this particular case, it was not possible for me to accept what was happening. I made sure that patients didn&#039;t suffer because of the quality of medicines made by Ranbaxy.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* While the investigations were on, did you worry about your and your family&#039;s safety?&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;Thakur&#039;s attorney Andrew Beato responds: The process of being a whistle blower is inherently complex. It is a long process and there are a range of issues that every whistle blower has to contend with, from the future ability to choose employment to personal safety. So, in this particular case, we made sure all of his concerns were properly addressed.&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&lt;em&gt;The Economic Times, 27 May, 2013, &lt;a href=&quot;http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms&quot; title=&quot;http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms&quot;&gt;http://economictimes.indiatimes.com/opinion/interviews/i-h&lt;br /&gt;ope-the-indian-law-protects-people-like-me-dinesh-thakur/a&lt;br /&gt;rticleshow/20284048.cms&lt;/a&gt;&lt;/em&gt; &lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&lt;strong&gt;Image Courtesy: The Economic Times&lt;/strong&gt; &lt;br /&gt;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>interviews/dinesh-thakur-an-ex-ranbaxy-employee-who-blew-the-whistle-on-the-company-interviewed-by-the-economic-times-21284.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>Interviews | Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, interviewed by The Economic Times | Im4change.org</title>
    <meta name="description" content="
-The Economic Times


Indian pharmaceutical company Ranbaxy recently paid $500 million to the US government to settle civil and criminal charges for making fraudulent statements to the US FDA and selling adulterated drugs in the US. Dinesh Thakur, an ex-Ranbaxy employee..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, interviewed by The Economic Times</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Economic Times<br /><br /><br />Indian pharmaceutical company Ranbaxy recently paid $500 million to the US government to settle civil and criminal charges for making fraudulent statements to the US FDA and selling adulterated drugs in the US. Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, talks to ET about the five-year long investigation and the future of generic drug companies in the US. Edited Excerpts:<br /><br /><em>* You think you would have found support from the Indian authorities had you carried this 'expose' in India?<br /></em><br />A FDA is probably a mature regulatory organisation globally. I have worked in this industry for long, apart from the two years in Ranbaxy. I know how FDA works, what laws and regulations are followed, so it was natural for me to contact FDA.<br /><br /><em>* The Fortune story on Ranbaxy had quite a few revelations. Did you approach the top management, like Malvinder Singh and inform him of what was happening?<br /></em><br />I was in touch with Dr Kumar, he was talking to the board. So, I was keeping him informed about my findings in the investigation.<br /><br /><em>* Have you met Malvinder Singh?<br /></em><br />I have met him many times. I used to run portfolio review meetings for the company since I was the head of portfolio management, and he was head of business. So, he used to attend those meetings. I am not sure if he remembers that, but yes I have met him.<br /><br /><em>* Malvinder Singh in an interview has maintained that he never met you, and doesn't know who you are. Your comments...<br /></em><br />I am sure he meets many people, and I am sure it is difficult for him to remember.<br /><br /><em>* The journey must have been quite frightening...<br /></em><br />There's no legal framework to do something like this in India. You had to work hard to get to every document, so it was very difficult to navigate.<br /><br /><em>* Do other Indian companies follow regulatory measures to the book?<br /></em><br />I have no idea what other Indian companies do, I have worked in only one Indian company and can speak about that company. So, I have no basis or information to talk about other companies.<br /><br /><em>* Do you think Indians should be worried about the quality of drugs that they take?<br /></em><br />That's a question Indian regulators must answer. I am not in a position to answer questions on behalf of the safety of medicines made by manufacturers in India. All I can say is that in this particular case, it was not possible for me to accept what was happening. I made sure that patients didn't suffer because of the quality of medicines made by Ranbaxy.<br /><br /><em>* While the investigations were on, did you worry about your and your family's safety?<br /></em><br />Thakur's attorney Andrew Beato responds: The process of being a whistle blower is inherently complex. It is a long process and there are a range of issues that every whistle blower has to contend with, from the future ability to choose employment to personal safety. So, in this particular case, we made sure all of his concerns were properly addressed.</div><div align="justify">&nbsp;</div><div align="justify"><em>The Economic Times, 27 May, 2013, <a href="http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms" title="http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms">http://economictimes.indiatimes.com/opinion/interviews/i-h<br />ope-the-indian-law-protects-people-like-me-dinesh-thakur/a<br />rticleshow/20284048.cms</a></em> </div><div align="justify">&nbsp;</div><div align="justify"><strong>Image Courtesy: The Economic Times</strong> <br /></div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67fcd85039908-trace').style.display = (document.getElementById('cakeErr67fcd85039908-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67fcd85039908-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67fcd85039908-code').style.display = (document.getElementById('cakeErr67fcd85039908-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67fcd85039908-context').style.display = (document.getElementById('cakeErr67fcd85039908-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67fcd85039908-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67fcd85039908-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 21139,
		&#039;title&#039; =&gt; &#039;Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, interviewed by The Economic Times&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Economic Times&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Indian pharmaceutical company Ranbaxy recently paid $500 million to the US government to settle civil and criminal charges for making fraudulent statements to the US FDA and selling adulterated drugs in the US. Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, talks to ET about the five-year long investigation and the future of generic drug companies in the US. Edited Excerpts:&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* You think you would have found support from the Indian authorities had you carried this &#039;expose&#039; in India?&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
A FDA is probably a mature regulatory organisation globally. I have worked in this industry for long, apart from the two years in Ranbaxy. I know how FDA works, what laws and regulations are followed, so it was natural for me to contact FDA.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* The Fortune story on Ranbaxy had quite a few revelations. Did you approach the top management, like Malvinder Singh and inform him of what was happening?&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
I was in touch with Dr Kumar, he was talking to the board. So, I was keeping him informed about my findings in the investigation.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* Have you met Malvinder Singh?&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
I have met him many times. I used to run portfolio review meetings for the company since I was the head of portfolio management, and he was head of business. So, he used to attend those meetings. I am not sure if he remembers that, but yes I have met him.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* Malvinder Singh in an interview has maintained that he never met you, and doesn&#039;t know who you are. Your comments...&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
I am sure he meets many people, and I am sure it is difficult for him to remember.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* The journey must have been quite frightening...&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
There&#039;s no legal framework to do something like this in India. You had to work hard to get to every document, so it was very difficult to navigate.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* Do other Indian companies follow regulatory measures to the book?&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
I have no idea what other Indian companies do, I have worked in only one Indian company and can speak about that company. So, I have no basis or information to talk about other companies.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* Do you think Indians should be worried about the quality of drugs that they take?&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
That&#039;s a question Indian regulators must answer. I am not in a position to answer questions on behalf of the safety of medicines made by manufacturers in India. All I can say is that in this particular case, it was not possible for me to accept what was happening. I made sure that patients didn&#039;t suffer because of the quality of medicines made by Ranbaxy.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* While the investigations were on, did you worry about your and your family&#039;s safety?&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
Thakur&#039;s attorney Andrew Beato responds: The process of being a whistle blower is inherently complex. It is a long process and there are a range of issues that every whistle blower has to contend with, from the future ability to choose employment to personal safety. So, in this particular case, we made sure all of his concerns were properly addressed.
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;em&gt;The Economic Times, 27 May, 2013, &lt;a href=&quot;http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms&quot;&gt;http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms&lt;/a&gt;&lt;/em&gt; 
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;strong&gt;Image Courtesy: The Economic Times&lt;/strong&gt; &lt;br /&gt;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Economic Times, 27 May, 2013, http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms&#039;,
		&#039;article_img&#039; =&gt; &#039;im4change_72Thakur.jpg&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;im4change_72Thakur.jpg&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 14,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;dinesh-thakur-an-ex-ranbaxy-employee-who-blew-the-whistle-on-the-company-interviewed-by-the-economic-times-21284&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 21284,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 21139,
	&#039;metaTitle&#039; =&gt; &#039;Interviews | Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, interviewed by The Economic Times&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Health,medicines,generic drugs,Ranbaxy,Whistleblower Protection Law&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Economic Times


Indian pharmaceutical company Ranbaxy recently paid $500 million to the US government to settle civil and criminal charges for making fraudulent statements to the US FDA and selling adulterated drugs in the US. Dinesh Thakur, an ex-Ranbaxy employee...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Economic Times&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Indian pharmaceutical company Ranbaxy recently paid $500 million to the US government to settle civil and criminal charges for making fraudulent statements to the US FDA and selling adulterated drugs in the US. Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, talks to ET about the five-year long investigation and the future of generic drug companies in the US. Edited Excerpts:&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* You think you would have found support from the Indian authorities had you carried this &#039;expose&#039; in India?&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;A FDA is probably a mature regulatory organisation globally. I have worked in this industry for long, apart from the two years in Ranbaxy. I know how FDA works, what laws and regulations are followed, so it was natural for me to contact FDA.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* The Fortune story on Ranbaxy had quite a few revelations. Did you approach the top management, like Malvinder Singh and inform him of what was happening?&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;I was in touch with Dr Kumar, he was talking to the board. So, I was keeping him informed about my findings in the investigation.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* Have you met Malvinder Singh?&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;I have met him many times. I used to run portfolio review meetings for the company since I was the head of portfolio management, and he was head of business. So, he used to attend those meetings. I am not sure if he remembers that, but yes I have met him.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* Malvinder Singh in an interview has maintained that he never met you, and doesn&#039;t know who you are. Your comments...&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;I am sure he meets many people, and I am sure it is difficult for him to remember.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* The journey must have been quite frightening...&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;There&#039;s no legal framework to do something like this in India. You had to work hard to get to every document, so it was very difficult to navigate.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* Do other Indian companies follow regulatory measures to the book?&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;I have no idea what other Indian companies do, I have worked in only one Indian company and can speak about that company. So, I have no basis or information to talk about other companies.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* Do you think Indians should be worried about the quality of drugs that they take?&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;That&#039;s a question Indian regulators must answer. I am not in a position to answer questions on behalf of the safety of medicines made by manufacturers in India. All I can say is that in this particular case, it was not possible for me to accept what was happening. I made sure that patients didn&#039;t suffer because of the quality of medicines made by Ranbaxy.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* While the investigations were on, did you worry about your and your family&#039;s safety?&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;Thakur&#039;s attorney Andrew Beato responds: The process of being a whistle blower is inherently complex. It is a long process and there are a range of issues that every whistle blower has to contend with, from the future ability to choose employment to personal safety. So, in this particular case, we made sure all of his concerns were properly addressed.&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&lt;em&gt;The Economic Times, 27 May, 2013, &lt;a href=&quot;http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms&quot; title=&quot;http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms&quot;&gt;http://economictimes.indiatimes.com/opinion/interviews/i-h&lt;br /&gt;ope-the-indian-law-protects-people-like-me-dinesh-thakur/a&lt;br /&gt;rticleshow/20284048.cms&lt;/a&gt;&lt;/em&gt; &lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&lt;strong&gt;Image Courtesy: The Economic Times&lt;/strong&gt; &lt;br /&gt;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 21139,
	&#039;title&#039; =&gt; &#039;Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, interviewed by The Economic Times&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Economic Times&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Indian pharmaceutical company Ranbaxy recently paid $500 million to the US government to settle civil and criminal charges for making fraudulent statements to the US FDA and selling adulterated drugs in the US. Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, talks to ET about the five-year long investigation and the future of generic drug companies in the US. Edited Excerpts:&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* You think you would have found support from the Indian authorities had you carried this &#039;expose&#039; in India?&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
A FDA is probably a mature regulatory organisation globally. I have worked in this industry for long, apart from the two years in Ranbaxy. I know how FDA works, what laws and regulations are followed, so it was natural for me to contact FDA.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* The Fortune story on Ranbaxy had quite a few revelations. Did you approach the top management, like Malvinder Singh and inform him of what was happening?&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
I was in touch with Dr Kumar, he was talking to the board. So, I was keeping him informed about my findings in the investigation.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* Have you met Malvinder Singh?&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
I have met him many times. I used to run portfolio review meetings for the company since I was the head of portfolio management, and he was head of business. So, he used to attend those meetings. I am not sure if he remembers that, but yes I have met him.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* Malvinder Singh in an interview has maintained that he never met you, and doesn&#039;t know who you are. Your comments...&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
I am sure he meets many people, and I am sure it is difficult for him to remember.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* The journey must have been quite frightening...&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
There&#039;s no legal framework to do something like this in India. You had to work hard to get to every document, so it was very difficult to navigate.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* Do other Indian companies follow regulatory measures to the book?&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
I have no idea what other Indian companies do, I have worked in only one Indian company and can speak about that company. So, I have no basis or information to talk about other companies.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* Do you think Indians should be worried about the quality of drugs that they take?&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
That&#039;s a question Indian regulators must answer. I am not in a position to answer questions on behalf of the safety of medicines made by manufacturers in India. All I can say is that in this particular case, it was not possible for me to accept what was happening. I made sure that patients didn&#039;t suffer because of the quality of medicines made by Ranbaxy.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* While the investigations were on, did you worry about your and your family&#039;s safety?&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
Thakur&#039;s attorney Andrew Beato responds: The process of being a whistle blower is inherently complex. It is a long process and there are a range of issues that every whistle blower has to contend with, from the future ability to choose employment to personal safety. So, in this particular case, we made sure all of his concerns were properly addressed.
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;em&gt;The Economic Times, 27 May, 2013, &lt;a href=&quot;http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms&quot;&gt;http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms&lt;/a&gt;&lt;/em&gt; 
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;strong&gt;Image Courtesy: The Economic Times&lt;/strong&gt; &lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Economic Times, 27 May, 2013, http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms&#039;,
	&#039;article_img&#039; =&gt; &#039;im4change_72Thakur.jpg&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;im4change_72Thakur.jpg&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 14,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;dinesh-thakur-an-ex-ranbaxy-employee-who-blew-the-whistle-on-the-company-interviewed-by-the-economic-times-21284&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 21284,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 21139
$metaTitle = &#039;Interviews | Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, interviewed by The Economic Times&#039;
$metaKeywords = &#039;Health,medicines,generic drugs,Ranbaxy,Whistleblower Protection Law&#039;
$metaDesc = &#039;
-The Economic Times


Indian pharmaceutical company Ranbaxy recently paid $500 million to the US government to settle civil and criminal charges for making fraudulent statements to the US FDA and selling adulterated drugs in the US. Dinesh Thakur, an ex-Ranbaxy employee...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Economic Times&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Indian pharmaceutical company Ranbaxy recently paid $500 million to the US government to settle civil and criminal charges for making fraudulent statements to the US FDA and selling adulterated drugs in the US. Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, talks to ET about the five-year long investigation and the future of generic drug companies in the US. Edited Excerpts:&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* You think you would have found support from the Indian authorities had you carried this &#039;expose&#039; in India?&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;A FDA is probably a mature regulatory organisation globally. I have worked in this industry for long, apart from the two years in Ranbaxy. I know how FDA works, what laws and regulations are followed, so it was natural for me to contact FDA.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* The Fortune story on Ranbaxy had quite a few revelations. Did you approach the top management, like Malvinder Singh and inform him of what was happening?&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;I was in touch with Dr Kumar, he was talking to the board. So, I was keeping him informed about my findings in the investigation.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* Have you met Malvinder Singh?&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;I have met him many times. I used to run portfolio review meetings for the company since I was the head of portfolio management, and he was head of business. So, he used to attend those meetings. I am not sure if he remembers that, but yes I have met him.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* Malvinder Singh in an interview has maintained that he never met you, and doesn&#039;t know who you are. Your comments...&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;I am sure he meets many people, and I am sure it is difficult for him to remember.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* The journey must have been quite frightening...&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;There&#039;s no legal framework to do something like this in India. You had to work hard to get to every document, so it was very difficult to navigate.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* Do other Indian companies follow regulatory measures to the book?&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;I have no idea what other Indian companies do, I have worked in only one Indian company and can speak about that company. So, I have no basis or information to talk about other companies.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* Do you think Indians should be worried about the quality of drugs that they take?&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;That&#039;s a question Indian regulators must answer. I am not in a position to answer questions on behalf of the safety of medicines made by manufacturers in India. All I can say is that in this particular case, it was not possible for me to accept what was happening. I made sure that patients didn&#039;t suffer because of the quality of medicines made by Ranbaxy.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* While the investigations were on, did you worry about your and your family&#039;s safety?&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;Thakur&#039;s attorney Andrew Beato responds: The process of being a whistle blower is inherently complex. It is a long process and there are a range of issues that every whistle blower has to contend with, from the future ability to choose employment to personal safety. So, in this particular case, we made sure all of his concerns were properly addressed.&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&lt;em&gt;The Economic Times, 27 May, 2013, &lt;a href=&quot;http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms&quot; title=&quot;http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms&quot;&gt;http://economictimes.indiatimes.com/opinion/interviews/i-h&lt;br /&gt;ope-the-indian-law-protects-people-like-me-dinesh-thakur/a&lt;br /&gt;rticleshow/20284048.cms&lt;/a&gt;&lt;/em&gt; &lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&lt;strong&gt;Image Courtesy: The Economic Times&lt;/strong&gt; &lt;br /&gt;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>interviews/dinesh-thakur-an-ex-ranbaxy-employee-who-blew-the-whistle-on-the-company-interviewed-by-the-economic-times-21284.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>Interviews | Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, interviewed by The Economic Times | Im4change.org</title>
    <meta name="description" content="
-The Economic Times


Indian pharmaceutical company Ranbaxy recently paid $500 million to the US government to settle civil and criminal charges for making fraudulent statements to the US FDA and selling adulterated drugs in the US. Dinesh Thakur, an ex-Ranbaxy employee..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, interviewed by The Economic Times</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Economic Times<br /><br /><br />Indian pharmaceutical company Ranbaxy recently paid $500 million to the US government to settle civil and criminal charges for making fraudulent statements to the US FDA and selling adulterated drugs in the US. Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, talks to ET about the five-year long investigation and the future of generic drug companies in the US. Edited Excerpts:<br /><br /><em>* You think you would have found support from the Indian authorities had you carried this 'expose' in India?<br /></em><br />A FDA is probably a mature regulatory organisation globally. I have worked in this industry for long, apart from the two years in Ranbaxy. I know how FDA works, what laws and regulations are followed, so it was natural for me to contact FDA.<br /><br /><em>* The Fortune story on Ranbaxy had quite a few revelations. Did you approach the top management, like Malvinder Singh and inform him of what was happening?<br /></em><br />I was in touch with Dr Kumar, he was talking to the board. So, I was keeping him informed about my findings in the investigation.<br /><br /><em>* Have you met Malvinder Singh?<br /></em><br />I have met him many times. I used to run portfolio review meetings for the company since I was the head of portfolio management, and he was head of business. So, he used to attend those meetings. I am not sure if he remembers that, but yes I have met him.<br /><br /><em>* Malvinder Singh in an interview has maintained that he never met you, and doesn't know who you are. Your comments...<br /></em><br />I am sure he meets many people, and I am sure it is difficult for him to remember.<br /><br /><em>* The journey must have been quite frightening...<br /></em><br />There's no legal framework to do something like this in India. You had to work hard to get to every document, so it was very difficult to navigate.<br /><br /><em>* Do other Indian companies follow regulatory measures to the book?<br /></em><br />I have no idea what other Indian companies do, I have worked in only one Indian company and can speak about that company. So, I have no basis or information to talk about other companies.<br /><br /><em>* Do you think Indians should be worried about the quality of drugs that they take?<br /></em><br />That's a question Indian regulators must answer. I am not in a position to answer questions on behalf of the safety of medicines made by manufacturers in India. All I can say is that in this particular case, it was not possible for me to accept what was happening. I made sure that patients didn't suffer because of the quality of medicines made by Ranbaxy.<br /><br /><em>* While the investigations were on, did you worry about your and your family's safety?<br /></em><br />Thakur's attorney Andrew Beato responds: The process of being a whistle blower is inherently complex. It is a long process and there are a range of issues that every whistle blower has to contend with, from the future ability to choose employment to personal safety. So, in this particular case, we made sure all of his concerns were properly addressed.</div><div align="justify">&nbsp;</div><div align="justify"><em>The Economic Times, 27 May, 2013, <a href="http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms" title="http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms">http://economictimes.indiatimes.com/opinion/interviews/i-h<br />ope-the-indian-law-protects-people-like-me-dinesh-thakur/a<br />rticleshow/20284048.cms</a></em> </div><div align="justify">&nbsp;</div><div align="justify"><strong>Image Courtesy: The Economic Times</strong> <br /></div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67fcd85039908-trace').style.display = (document.getElementById('cakeErr67fcd85039908-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67fcd85039908-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67fcd85039908-code').style.display = (document.getElementById('cakeErr67fcd85039908-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67fcd85039908-context').style.display = (document.getElementById('cakeErr67fcd85039908-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67fcd85039908-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67fcd85039908-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 21139,
		&#039;title&#039; =&gt; &#039;Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, interviewed by The Economic Times&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Economic Times&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Indian pharmaceutical company Ranbaxy recently paid $500 million to the US government to settle civil and criminal charges for making fraudulent statements to the US FDA and selling adulterated drugs in the US. Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, talks to ET about the five-year long investigation and the future of generic drug companies in the US. Edited Excerpts:&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* You think you would have found support from the Indian authorities had you carried this &#039;expose&#039; in India?&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
A FDA is probably a mature regulatory organisation globally. I have worked in this industry for long, apart from the two years in Ranbaxy. I know how FDA works, what laws and regulations are followed, so it was natural for me to contact FDA.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* The Fortune story on Ranbaxy had quite a few revelations. Did you approach the top management, like Malvinder Singh and inform him of what was happening?&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
I was in touch with Dr Kumar, he was talking to the board. So, I was keeping him informed about my findings in the investigation.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* Have you met Malvinder Singh?&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
I have met him many times. I used to run portfolio review meetings for the company since I was the head of portfolio management, and he was head of business. So, he used to attend those meetings. I am not sure if he remembers that, but yes I have met him.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* Malvinder Singh in an interview has maintained that he never met you, and doesn&#039;t know who you are. Your comments...&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
I am sure he meets many people, and I am sure it is difficult for him to remember.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* The journey must have been quite frightening...&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
There&#039;s no legal framework to do something like this in India. You had to work hard to get to every document, so it was very difficult to navigate.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* Do other Indian companies follow regulatory measures to the book?&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
I have no idea what other Indian companies do, I have worked in only one Indian company and can speak about that company. So, I have no basis or information to talk about other companies.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* Do you think Indians should be worried about the quality of drugs that they take?&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
That&#039;s a question Indian regulators must answer. I am not in a position to answer questions on behalf of the safety of medicines made by manufacturers in India. All I can say is that in this particular case, it was not possible for me to accept what was happening. I made sure that patients didn&#039;t suffer because of the quality of medicines made by Ranbaxy.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* While the investigations were on, did you worry about your and your family&#039;s safety?&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
Thakur&#039;s attorney Andrew Beato responds: The process of being a whistle blower is inherently complex. It is a long process and there are a range of issues that every whistle blower has to contend with, from the future ability to choose employment to personal safety. So, in this particular case, we made sure all of his concerns were properly addressed.
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;em&gt;The Economic Times, 27 May, 2013, &lt;a href=&quot;http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms&quot;&gt;http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms&lt;/a&gt;&lt;/em&gt; 
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;strong&gt;Image Courtesy: The Economic Times&lt;/strong&gt; &lt;br /&gt;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Economic Times, 27 May, 2013, http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms&#039;,
		&#039;article_img&#039; =&gt; &#039;im4change_72Thakur.jpg&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;im4change_72Thakur.jpg&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 14,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;dinesh-thakur-an-ex-ranbaxy-employee-who-blew-the-whistle-on-the-company-interviewed-by-the-economic-times-21284&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 21284,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 21139,
	&#039;metaTitle&#039; =&gt; &#039;Interviews | Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, interviewed by The Economic Times&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Health,medicines,generic drugs,Ranbaxy,Whistleblower Protection Law&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Economic Times


Indian pharmaceutical company Ranbaxy recently paid $500 million to the US government to settle civil and criminal charges for making fraudulent statements to the US FDA and selling adulterated drugs in the US. Dinesh Thakur, an ex-Ranbaxy employee...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Economic Times&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Indian pharmaceutical company Ranbaxy recently paid $500 million to the US government to settle civil and criminal charges for making fraudulent statements to the US FDA and selling adulterated drugs in the US. Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, talks to ET about the five-year long investigation and the future of generic drug companies in the US. Edited Excerpts:&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* You think you would have found support from the Indian authorities had you carried this &#039;expose&#039; in India?&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;A FDA is probably a mature regulatory organisation globally. I have worked in this industry for long, apart from the two years in Ranbaxy. I know how FDA works, what laws and regulations are followed, so it was natural for me to contact FDA.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* The Fortune story on Ranbaxy had quite a few revelations. Did you approach the top management, like Malvinder Singh and inform him of what was happening?&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;I was in touch with Dr Kumar, he was talking to the board. So, I was keeping him informed about my findings in the investigation.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* Have you met Malvinder Singh?&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;I have met him many times. I used to run portfolio review meetings for the company since I was the head of portfolio management, and he was head of business. So, he used to attend those meetings. I am not sure if he remembers that, but yes I have met him.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* Malvinder Singh in an interview has maintained that he never met you, and doesn&#039;t know who you are. Your comments...&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;I am sure he meets many people, and I am sure it is difficult for him to remember.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* The journey must have been quite frightening...&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;There&#039;s no legal framework to do something like this in India. You had to work hard to get to every document, so it was very difficult to navigate.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* Do other Indian companies follow regulatory measures to the book?&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;I have no idea what other Indian companies do, I have worked in only one Indian company and can speak about that company. So, I have no basis or information to talk about other companies.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* Do you think Indians should be worried about the quality of drugs that they take?&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;That&#039;s a question Indian regulators must answer. I am not in a position to answer questions on behalf of the safety of medicines made by manufacturers in India. All I can say is that in this particular case, it was not possible for me to accept what was happening. I made sure that patients didn&#039;t suffer because of the quality of medicines made by Ranbaxy.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* While the investigations were on, did you worry about your and your family&#039;s safety?&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;Thakur&#039;s attorney Andrew Beato responds: The process of being a whistle blower is inherently complex. It is a long process and there are a range of issues that every whistle blower has to contend with, from the future ability to choose employment to personal safety. So, in this particular case, we made sure all of his concerns were properly addressed.&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&lt;em&gt;The Economic Times, 27 May, 2013, &lt;a href=&quot;http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms&quot; title=&quot;http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms&quot;&gt;http://economictimes.indiatimes.com/opinion/interviews/i-h&lt;br /&gt;ope-the-indian-law-protects-people-like-me-dinesh-thakur/a&lt;br /&gt;rticleshow/20284048.cms&lt;/a&gt;&lt;/em&gt; &lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&lt;strong&gt;Image Courtesy: The Economic Times&lt;/strong&gt; &lt;br /&gt;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 21139,
	&#039;title&#039; =&gt; &#039;Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, interviewed by The Economic Times&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Economic Times&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Indian pharmaceutical company Ranbaxy recently paid $500 million to the US government to settle civil and criminal charges for making fraudulent statements to the US FDA and selling adulterated drugs in the US. Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, talks to ET about the five-year long investigation and the future of generic drug companies in the US. Edited Excerpts:&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* You think you would have found support from the Indian authorities had you carried this &#039;expose&#039; in India?&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
A FDA is probably a mature regulatory organisation globally. I have worked in this industry for long, apart from the two years in Ranbaxy. I know how FDA works, what laws and regulations are followed, so it was natural for me to contact FDA.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* The Fortune story on Ranbaxy had quite a few revelations. Did you approach the top management, like Malvinder Singh and inform him of what was happening?&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
I was in touch with Dr Kumar, he was talking to the board. So, I was keeping him informed about my findings in the investigation.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* Have you met Malvinder Singh?&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
I have met him many times. I used to run portfolio review meetings for the company since I was the head of portfolio management, and he was head of business. So, he used to attend those meetings. I am not sure if he remembers that, but yes I have met him.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* Malvinder Singh in an interview has maintained that he never met you, and doesn&#039;t know who you are. Your comments...&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
I am sure he meets many people, and I am sure it is difficult for him to remember.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* The journey must have been quite frightening...&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
There&#039;s no legal framework to do something like this in India. You had to work hard to get to every document, so it was very difficult to navigate.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* Do other Indian companies follow regulatory measures to the book?&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
I have no idea what other Indian companies do, I have worked in only one Indian company and can speak about that company. So, I have no basis or information to talk about other companies.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* Do you think Indians should be worried about the quality of drugs that they take?&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
That&#039;s a question Indian regulators must answer. I am not in a position to answer questions on behalf of the safety of medicines made by manufacturers in India. All I can say is that in this particular case, it was not possible for me to accept what was happening. I made sure that patients didn&#039;t suffer because of the quality of medicines made by Ranbaxy.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;* While the investigations were on, did you worry about your and your family&#039;s safety?&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
Thakur&#039;s attorney Andrew Beato responds: The process of being a whistle blower is inherently complex. It is a long process and there are a range of issues that every whistle blower has to contend with, from the future ability to choose employment to personal safety. So, in this particular case, we made sure all of his concerns were properly addressed.
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;em&gt;The Economic Times, 27 May, 2013, &lt;a href=&quot;http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms&quot;&gt;http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms&lt;/a&gt;&lt;/em&gt; 
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;strong&gt;Image Courtesy: The Economic Times&lt;/strong&gt; &lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Economic Times, 27 May, 2013, http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms&#039;,
	&#039;article_img&#039; =&gt; &#039;im4change_72Thakur.jpg&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;im4change_72Thakur.jpg&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 14,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;dinesh-thakur-an-ex-ranbaxy-employee-who-blew-the-whistle-on-the-company-interviewed-by-the-economic-times-21284&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 21284,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 21139
$metaTitle = &#039;Interviews | Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, interviewed by The Economic Times&#039;
$metaKeywords = &#039;Health,medicines,generic drugs,Ranbaxy,Whistleblower Protection Law&#039;
$metaDesc = &#039;
-The Economic Times


Indian pharmaceutical company Ranbaxy recently paid $500 million to the US government to settle civil and criminal charges for making fraudulent statements to the US FDA and selling adulterated drugs in the US. Dinesh Thakur, an ex-Ranbaxy employee...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Economic Times&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Indian pharmaceutical company Ranbaxy recently paid $500 million to the US government to settle civil and criminal charges for making fraudulent statements to the US FDA and selling adulterated drugs in the US. Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, talks to ET about the five-year long investigation and the future of generic drug companies in the US. Edited Excerpts:&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* You think you would have found support from the Indian authorities had you carried this &#039;expose&#039; in India?&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;A FDA is probably a mature regulatory organisation globally. I have worked in this industry for long, apart from the two years in Ranbaxy. I know how FDA works, what laws and regulations are followed, so it was natural for me to contact FDA.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* The Fortune story on Ranbaxy had quite a few revelations. Did you approach the top management, like Malvinder Singh and inform him of what was happening?&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;I was in touch with Dr Kumar, he was talking to the board. So, I was keeping him informed about my findings in the investigation.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* Have you met Malvinder Singh?&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;I have met him many times. I used to run portfolio review meetings for the company since I was the head of portfolio management, and he was head of business. So, he used to attend those meetings. I am not sure if he remembers that, but yes I have met him.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* Malvinder Singh in an interview has maintained that he never met you, and doesn&#039;t know who you are. Your comments...&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;I am sure he meets many people, and I am sure it is difficult for him to remember.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* The journey must have been quite frightening...&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;There&#039;s no legal framework to do something like this in India. You had to work hard to get to every document, so it was very difficult to navigate.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* Do other Indian companies follow regulatory measures to the book?&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;I have no idea what other Indian companies do, I have worked in only one Indian company and can speak about that company. So, I have no basis or information to talk about other companies.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* Do you think Indians should be worried about the quality of drugs that they take?&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;That&#039;s a question Indian regulators must answer. I am not in a position to answer questions on behalf of the safety of medicines made by manufacturers in India. All I can say is that in this particular case, it was not possible for me to accept what was happening. I made sure that patients didn&#039;t suffer because of the quality of medicines made by Ranbaxy.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;* While the investigations were on, did you worry about your and your family&#039;s safety?&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;Thakur&#039;s attorney Andrew Beato responds: The process of being a whistle blower is inherently complex. It is a long process and there are a range of issues that every whistle blower has to contend with, from the future ability to choose employment to personal safety. So, in this particular case, we made sure all of his concerns were properly addressed.&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&lt;em&gt;The Economic Times, 27 May, 2013, &lt;a href=&quot;http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms&quot; title=&quot;http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms&quot;&gt;http://economictimes.indiatimes.com/opinion/interviews/i-h&lt;br /&gt;ope-the-indian-law-protects-people-like-me-dinesh-thakur/a&lt;br /&gt;rticleshow/20284048.cms&lt;/a&gt;&lt;/em&gt; &lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&lt;strong&gt;Image Courtesy: The Economic Times&lt;/strong&gt; &lt;br /&gt;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>interviews/dinesh-thakur-an-ex-ranbaxy-employee-who-blew-the-whistle-on-the-company-interviewed-by-the-economic-times-21284.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>Interviews | Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, interviewed by The Economic Times | Im4change.org</title>
    <meta name="description" content="
-The Economic Times


Indian pharmaceutical company Ranbaxy recently paid $500 million to the US government to settle civil and criminal charges for making fraudulent statements to the US FDA and selling adulterated drugs in the US. Dinesh Thakur, an ex-Ranbaxy employee..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, interviewed by The Economic Times</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Economic Times<br /><br /><br />Indian pharmaceutical company Ranbaxy recently paid $500 million to the US government to settle civil and criminal charges for making fraudulent statements to the US FDA and selling adulterated drugs in the US. Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, talks to ET about the five-year long investigation and the future of generic drug companies in the US. Edited Excerpts:<br /><br /><em>* You think you would have found support from the Indian authorities had you carried this 'expose' in India?<br /></em><br />A FDA is probably a mature regulatory organisation globally. I have worked in this industry for long, apart from the two years in Ranbaxy. I know how FDA works, what laws and regulations are followed, so it was natural for me to contact FDA.<br /><br /><em>* The Fortune story on Ranbaxy had quite a few revelations. Did you approach the top management, like Malvinder Singh and inform him of what was happening?<br /></em><br />I was in touch with Dr Kumar, he was talking to the board. So, I was keeping him informed about my findings in the investigation.<br /><br /><em>* Have you met Malvinder Singh?<br /></em><br />I have met him many times. I used to run portfolio review meetings for the company since I was the head of portfolio management, and he was head of business. So, he used to attend those meetings. I am not sure if he remembers that, but yes I have met him.<br /><br /><em>* Malvinder Singh in an interview has maintained that he never met you, and doesn't know who you are. Your comments...<br /></em><br />I am sure he meets many people, and I am sure it is difficult for him to remember.<br /><br /><em>* The journey must have been quite frightening...<br /></em><br />There's no legal framework to do something like this in India. You had to work hard to get to every document, so it was very difficult to navigate.<br /><br /><em>* Do other Indian companies follow regulatory measures to the book?<br /></em><br />I have no idea what other Indian companies do, I have worked in only one Indian company and can speak about that company. So, I have no basis or information to talk about other companies.<br /><br /><em>* Do you think Indians should be worried about the quality of drugs that they take?<br /></em><br />That's a question Indian regulators must answer. I am not in a position to answer questions on behalf of the safety of medicines made by manufacturers in India. All I can say is that in this particular case, it was not possible for me to accept what was happening. I made sure that patients didn't suffer because of the quality of medicines made by Ranbaxy.<br /><br /><em>* While the investigations were on, did you worry about your and your family's safety?<br /></em><br />Thakur's attorney Andrew Beato responds: The process of being a whistle blower is inherently complex. It is a long process and there are a range of issues that every whistle blower has to contend with, from the future ability to choose employment to personal safety. So, in this particular case, we made sure all of his concerns were properly addressed.</div><div align="justify">&nbsp;</div><div align="justify"><em>The Economic Times, 27 May, 2013, <a href="http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms" title="http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms">http://economictimes.indiatimes.com/opinion/interviews/i-h<br />ope-the-indian-law-protects-people-like-me-dinesh-thakur/a<br />rticleshow/20284048.cms</a></em> </div><div align="justify">&nbsp;</div><div align="justify"><strong>Image Courtesy: The Economic Times</strong> <br /></div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 21139,
		'title' => 'Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, interviewed by The Economic Times',
		'subheading' => '',
		'description' => '<div align="justify">
-The Economic Times<br />
<br />
<br />
Indian pharmaceutical company Ranbaxy recently paid $500 million to the US government to settle civil and criminal charges for making fraudulent statements to the US FDA and selling adulterated drugs in the US. Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, talks to ET about the five-year long investigation and the future of generic drug companies in the US. Edited Excerpts:<br />
<br />
<em>* You think you would have found support from the Indian authorities had you carried this 'expose' in India?<br />
</em><br />
A FDA is probably a mature regulatory organisation globally. I have worked in this industry for long, apart from the two years in Ranbaxy. I know how FDA works, what laws and regulations are followed, so it was natural for me to contact FDA.<br />
<br />
<em>* The Fortune story on Ranbaxy had quite a few revelations. Did you approach the top management, like Malvinder Singh and inform him of what was happening?<br />
</em><br />
I was in touch with Dr Kumar, he was talking to the board. So, I was keeping him informed about my findings in the investigation.<br />
<br />
<em>* Have you met Malvinder Singh?<br />
</em><br />
I have met him many times. I used to run portfolio review meetings for the company since I was the head of portfolio management, and he was head of business. So, he used to attend those meetings. I am not sure if he remembers that, but yes I have met him.<br />
<br />
<em>* Malvinder Singh in an interview has maintained that he never met you, and doesn't know who you are. Your comments...<br />
</em><br />
I am sure he meets many people, and I am sure it is difficult for him to remember.<br />
<br />
<em>* The journey must have been quite frightening...<br />
</em><br />
There's no legal framework to do something like this in India. You had to work hard to get to every document, so it was very difficult to navigate.<br />
<br />
<em>* Do other Indian companies follow regulatory measures to the book?<br />
</em><br />
I have no idea what other Indian companies do, I have worked in only one Indian company and can speak about that company. So, I have no basis or information to talk about other companies.<br />
<br />
<em>* Do you think Indians should be worried about the quality of drugs that they take?<br />
</em><br />
That's a question Indian regulators must answer. I am not in a position to answer questions on behalf of the safety of medicines made by manufacturers in India. All I can say is that in this particular case, it was not possible for me to accept what was happening. I made sure that patients didn't suffer because of the quality of medicines made by Ranbaxy.<br />
<br />
<em>* While the investigations were on, did you worry about your and your family's safety?<br />
</em><br />
Thakur's attorney Andrew Beato responds: The process of being a whistle blower is inherently complex. It is a long process and there are a range of issues that every whistle blower has to contend with, from the future ability to choose employment to personal safety. So, in this particular case, we made sure all of his concerns were properly addressed.
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
<em>The Economic Times, 27 May, 2013, <a href="http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms">http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms</a></em> 
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
<strong>Image Courtesy: The Economic Times</strong> <br />
</div>',
		'credit_writer' => 'The Economic Times, 27 May, 2013, http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms',
		'article_img' => 'im4change_72Thakur.jpg',
		'article_img_thumb' => 'im4change_72Thakur.jpg',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 14,
		'tag_keyword' => '',
		'seo_url' => 'dinesh-thakur-an-ex-ranbaxy-employee-who-blew-the-whistle-on-the-company-interviewed-by-the-economic-times-21284',
		'meta_title' => null,
		'meta_keywords' => null,
		'meta_description' => null,
		'noindex' => (int) 0,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => (int) 21284,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 21139,
	'metaTitle' => 'Interviews | Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, interviewed by The Economic Times',
	'metaKeywords' => 'Health,medicines,generic drugs,Ranbaxy,Whistleblower Protection Law',
	'metaDesc' => '
-The Economic Times


Indian pharmaceutical company Ranbaxy recently paid $500 million to the US government to settle civil and criminal charges for making fraudulent statements to the US FDA and selling adulterated drugs in the US. Dinesh Thakur, an ex-Ranbaxy employee...',
	'disp' => '<div align="justify">-The Economic Times<br /><br /><br />Indian pharmaceutical company Ranbaxy recently paid $500 million to the US government to settle civil and criminal charges for making fraudulent statements to the US FDA and selling adulterated drugs in the US. Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, talks to ET about the five-year long investigation and the future of generic drug companies in the US. Edited Excerpts:<br /><br /><em>* You think you would have found support from the Indian authorities had you carried this 'expose' in India?<br /></em><br />A FDA is probably a mature regulatory organisation globally. I have worked in this industry for long, apart from the two years in Ranbaxy. I know how FDA works, what laws and regulations are followed, so it was natural for me to contact FDA.<br /><br /><em>* The Fortune story on Ranbaxy had quite a few revelations. Did you approach the top management, like Malvinder Singh and inform him of what was happening?<br /></em><br />I was in touch with Dr Kumar, he was talking to the board. So, I was keeping him informed about my findings in the investigation.<br /><br /><em>* Have you met Malvinder Singh?<br /></em><br />I have met him many times. I used to run portfolio review meetings for the company since I was the head of portfolio management, and he was head of business. So, he used to attend those meetings. I am not sure if he remembers that, but yes I have met him.<br /><br /><em>* Malvinder Singh in an interview has maintained that he never met you, and doesn't know who you are. Your comments...<br /></em><br />I am sure he meets many people, and I am sure it is difficult for him to remember.<br /><br /><em>* The journey must have been quite frightening...<br /></em><br />There's no legal framework to do something like this in India. You had to work hard to get to every document, so it was very difficult to navigate.<br /><br /><em>* Do other Indian companies follow regulatory measures to the book?<br /></em><br />I have no idea what other Indian companies do, I have worked in only one Indian company and can speak about that company. So, I have no basis or information to talk about other companies.<br /><br /><em>* Do you think Indians should be worried about the quality of drugs that they take?<br /></em><br />That's a question Indian regulators must answer. I am not in a position to answer questions on behalf of the safety of medicines made by manufacturers in India. All I can say is that in this particular case, it was not possible for me to accept what was happening. I made sure that patients didn't suffer because of the quality of medicines made by Ranbaxy.<br /><br /><em>* While the investigations were on, did you worry about your and your family's safety?<br /></em><br />Thakur's attorney Andrew Beato responds: The process of being a whistle blower is inherently complex. It is a long process and there are a range of issues that every whistle blower has to contend with, from the future ability to choose employment to personal safety. So, in this particular case, we made sure all of his concerns were properly addressed.</div><div align="justify">&nbsp;</div><div align="justify"><em>The Economic Times, 27 May, 2013, <a href="http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms" title="http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms">http://economictimes.indiatimes.com/opinion/interviews/i-h<br />ope-the-indian-law-protects-people-like-me-dinesh-thakur/a<br />rticleshow/20284048.cms</a></em> </div><div align="justify">&nbsp;</div><div align="justify"><strong>Image Courtesy: The Economic Times</strong> <br /></div>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 21139,
	'title' => 'Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, interviewed by The Economic Times',
	'subheading' => '',
	'description' => '<div align="justify">
-The Economic Times<br />
<br />
<br />
Indian pharmaceutical company Ranbaxy recently paid $500 million to the US government to settle civil and criminal charges for making fraudulent statements to the US FDA and selling adulterated drugs in the US. Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, talks to ET about the five-year long investigation and the future of generic drug companies in the US. Edited Excerpts:<br />
<br />
<em>* You think you would have found support from the Indian authorities had you carried this 'expose' in India?<br />
</em><br />
A FDA is probably a mature regulatory organisation globally. I have worked in this industry for long, apart from the two years in Ranbaxy. I know how FDA works, what laws and regulations are followed, so it was natural for me to contact FDA.<br />
<br />
<em>* The Fortune story on Ranbaxy had quite a few revelations. Did you approach the top management, like Malvinder Singh and inform him of what was happening?<br />
</em><br />
I was in touch with Dr Kumar, he was talking to the board. So, I was keeping him informed about my findings in the investigation.<br />
<br />
<em>* Have you met Malvinder Singh?<br />
</em><br />
I have met him many times. I used to run portfolio review meetings for the company since I was the head of portfolio management, and he was head of business. So, he used to attend those meetings. I am not sure if he remembers that, but yes I have met him.<br />
<br />
<em>* Malvinder Singh in an interview has maintained that he never met you, and doesn't know who you are. Your comments...<br />
</em><br />
I am sure he meets many people, and I am sure it is difficult for him to remember.<br />
<br />
<em>* The journey must have been quite frightening...<br />
</em><br />
There's no legal framework to do something like this in India. You had to work hard to get to every document, so it was very difficult to navigate.<br />
<br />
<em>* Do other Indian companies follow regulatory measures to the book?<br />
</em><br />
I have no idea what other Indian companies do, I have worked in only one Indian company and can speak about that company. So, I have no basis or information to talk about other companies.<br />
<br />
<em>* Do you think Indians should be worried about the quality of drugs that they take?<br />
</em><br />
That's a question Indian regulators must answer. I am not in a position to answer questions on behalf of the safety of medicines made by manufacturers in India. All I can say is that in this particular case, it was not possible for me to accept what was happening. I made sure that patients didn't suffer because of the quality of medicines made by Ranbaxy.<br />
<br />
<em>* While the investigations were on, did you worry about your and your family's safety?<br />
</em><br />
Thakur's attorney Andrew Beato responds: The process of being a whistle blower is inherently complex. It is a long process and there are a range of issues that every whistle blower has to contend with, from the future ability to choose employment to personal safety. So, in this particular case, we made sure all of his concerns were properly addressed.
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
<em>The Economic Times, 27 May, 2013, <a href="http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms">http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms</a></em> 
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
<strong>Image Courtesy: The Economic Times</strong> <br />
</div>',
	'credit_writer' => 'The Economic Times, 27 May, 2013, http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms',
	'article_img' => 'im4change_72Thakur.jpg',
	'article_img_thumb' => 'im4change_72Thakur.jpg',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 14,
	'tag_keyword' => '',
	'seo_url' => 'dinesh-thakur-an-ex-ranbaxy-employee-who-blew-the-whistle-on-the-company-interviewed-by-the-economic-times-21284',
	'meta_title' => null,
	'meta_keywords' => null,
	'meta_description' => null,
	'noindex' => (int) 0,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => (int) 21284,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {},
		(int) 1 => object(Cake\ORM\Entity) {},
		(int) 2 => object(Cake\ORM\Entity) {},
		(int) 3 => object(Cake\ORM\Entity) {},
		(int) 4 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 21139
$metaTitle = 'Interviews | Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, interviewed by The Economic Times'
$metaKeywords = 'Health,medicines,generic drugs,Ranbaxy,Whistleblower Protection Law'
$metaDesc = '
-The Economic Times


Indian pharmaceutical company Ranbaxy recently paid $500 million to the US government to settle civil and criminal charges for making fraudulent statements to the US FDA and selling adulterated drugs in the US. Dinesh Thakur, an ex-Ranbaxy employee...'
$disp = '<div align="justify">-The Economic Times<br /><br /><br />Indian pharmaceutical company Ranbaxy recently paid $500 million to the US government to settle civil and criminal charges for making fraudulent statements to the US FDA and selling adulterated drugs in the US. Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, talks to ET about the five-year long investigation and the future of generic drug companies in the US. Edited Excerpts:<br /><br /><em>* You think you would have found support from the Indian authorities had you carried this 'expose' in India?<br /></em><br />A FDA is probably a mature regulatory organisation globally. I have worked in this industry for long, apart from the two years in Ranbaxy. I know how FDA works, what laws and regulations are followed, so it was natural for me to contact FDA.<br /><br /><em>* The Fortune story on Ranbaxy had quite a few revelations. Did you approach the top management, like Malvinder Singh and inform him of what was happening?<br /></em><br />I was in touch with Dr Kumar, he was talking to the board. So, I was keeping him informed about my findings in the investigation.<br /><br /><em>* Have you met Malvinder Singh?<br /></em><br />I have met him many times. I used to run portfolio review meetings for the company since I was the head of portfolio management, and he was head of business. So, he used to attend those meetings. I am not sure if he remembers that, but yes I have met him.<br /><br /><em>* Malvinder Singh in an interview has maintained that he never met you, and doesn't know who you are. Your comments...<br /></em><br />I am sure he meets many people, and I am sure it is difficult for him to remember.<br /><br /><em>* The journey must have been quite frightening...<br /></em><br />There's no legal framework to do something like this in India. You had to work hard to get to every document, so it was very difficult to navigate.<br /><br /><em>* Do other Indian companies follow regulatory measures to the book?<br /></em><br />I have no idea what other Indian companies do, I have worked in only one Indian company and can speak about that company. So, I have no basis or information to talk about other companies.<br /><br /><em>* Do you think Indians should be worried about the quality of drugs that they take?<br /></em><br />That's a question Indian regulators must answer. I am not in a position to answer questions on behalf of the safety of medicines made by manufacturers in India. All I can say is that in this particular case, it was not possible for me to accept what was happening. I made sure that patients didn't suffer because of the quality of medicines made by Ranbaxy.<br /><br /><em>* While the investigations were on, did you worry about your and your family's safety?<br /></em><br />Thakur's attorney Andrew Beato responds: The process of being a whistle blower is inherently complex. It is a long process and there are a range of issues that every whistle blower has to contend with, from the future ability to choose employment to personal safety. So, in this particular case, we made sure all of his concerns were properly addressed.</div><div align="justify">&nbsp;</div><div align="justify"><em>The Economic Times, 27 May, 2013, <a href="http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms" title="http://economictimes.indiatimes.com/opinion/interviews/i-hope-the-indian-law-protects-people-like-me-dinesh-thakur/articleshow/20284048.cms">http://economictimes.indiatimes.com/opinion/interviews/i-h<br />ope-the-indian-law-protects-people-like-me-dinesh-thakur/a<br />rticleshow/20284048.cms</a></em> </div><div align="justify">&nbsp;</div><div align="justify"><strong>Image Courtesy: The Economic Times</strong> <br /></div>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, interviewed by The Economic Times

-The Economic Times Indian pharmaceutical company Ranbaxy recently paid $500 million to the US government to settle civil and criminal charges for making fraudulent statements to the US FDA and selling adulterated drugs in the US. Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, talks to ET about the five-year long investigation and the future of generic drug companies in the US. Edited Excerpts: * You think you would have found support from the Indian authorities had you carried this 'expose' in India? A FDA is probably a mature regulatory organisation globally. I have worked in this industry for long, apart from the two years in Ranbaxy. I know how FDA works, what laws and regulations are followed, so it was natural for me to contact FDA. * The Fortune story on Ranbaxy had quite a few revelations. Did you approach the top management, like Malvinder Singh and inform him of what was happening? I was in touch with Dr Kumar, he was talking to the board. So, I was keeping him informed about my findings in the investigation. * Have you met Malvinder Singh? I have met him many times. I used to run portfolio review meetings for the company since I was the head of portfolio management, and he was head of business. So, he used to attend those meetings. I am not sure if he remembers that, but yes I have met him. * Malvinder Singh in an interview has maintained that he never met you, and doesn't know who you are. Your comments... I am sure he meets many people, and I am sure it is difficult for him to remember. * The journey must have been quite frightening... There's no legal framework to do something like this in India. You had to work hard to get to every document, so it was very difficult to navigate. * Do other Indian companies follow regulatory measures to the book? I have no idea what other Indian companies do, I have worked in only one Indian company and can speak about that company. So, I have no basis or information to talk about other companies. * Do you think Indians should be worried about the quality of drugs that they take? That's a question Indian regulators must answer. I am not in a position to answer questions on behalf of the safety of medicines made by manufacturers in India. All I can say is that in this particular case, it was not possible for me to accept what was happening. I made sure that patients didn't suffer because of the quality of medicines made by Ranbaxy. * While the investigations were on, did you worry about your and your family's safety? Thakur's attorney Andrew Beato responds: The process of being a whistle blower is inherently complex. It is a long process and there are a range of issues that every whistle blower has to contend with, from the future ability to choose employment to personal safety. So, in this particular case, we made sure all of his concerns were properly addressed.   The Economic Times, 27 May, 2013, http://economictimes.indiatimes.com/opinion/interviews/i-h ope-the-indian-law-protects-people-like-me-dinesh-thakur/a rticleshow/20284048.cms   Image Courtesy: The Economic Times